KEVIN W QUINLAN Insider Trading $ANIK Anika Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN W QUINLAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN W QUINLAN. KEVIN W QUINLAN is Chief Financial Officer in Anika Therapeutics, Inc. ($ANIK).
KEVIN W QUINLAN in Anika Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of KEVIN W QUINLAN: Chief Financial Officer
Holdings: 11,744 shares
Current Value: $590,723
Latest Transaction: Mar 30 2009
$ANIK Market Capitalization: $733.34M
$ANIK Previous Close: $50.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN W QUINLAN in Anika Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2009 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Grant | A | 0.00 | 6,744 | 0 | 11,744 | 5 K to 11.7 K (+134.88 %) |
| Mar 03 2009 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Option Exercise | A | 3.05 | 30,000 | 91,500 | 30,000 | |
| Nov 10 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 5.20 | 1,000 | 5,200 | 5,000 | 4 K to 5 K (+25.00 %) |
| Nov 10 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 5.34 | 1,000 | 5,340 | 4,000 | 3 K to 4 K (+33.33 %) |
| Mar 19 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 8.30 | 900 | 7,470 | 3,000 | 2.1 K to 3 K (+42.86 %) |
| Mar 19 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 8.29 | 800 | 6,632 | 2,100 | 1.3 K to 2.1 K (+61.54 %) |
| Mar 19 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 8.28 | 200 | 1,656 | 1,300 | 1.1 K to 1.3 K (+18.18 %) |
| Mar 19 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 8.20 | 100 | 820 | 1,100 | 1,000 to 1.1 K (+10.00 %) |
| Mar 12 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 9.80 | 500 | 4,900 | 1,000 | 500 to 1,000 (+100.00 %) |
| Mar 12 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 9.95 | 500 | 4,975 | 500 | 0 to 500 |
Page: 1